Quanterix Corporation (QTRX)
USD 5.84
(-6.04%)
USD 5.84
(-6.04%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 78.08 Million USD | 3.75% |
| 2022 | 75.25 Million USD | 24.24% |
| 2021 | 60.57 Million USD | -6.69% |
| 2020 | 64.92 Million USD | 57.22% |
| 2019 | 41.29 Million USD | 58.38% |
| 2018 | 26.07 Million USD | 0.61% |
| 2017 | 25.91 Million USD | 9.61% |
| 2016 | 23.64 Million USD | 4.86% |
| 2015 | 22.54 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 74.53 Million USD | 6.01% |
| 2024 Q1 | 70.31 Million USD | -9.95% |
| 2023 Q1 | 69.98 Million USD | -7.01% |
| 2023 FY | 78.08 Million USD | 3.75% |
| 2023 Q4 | 78.08 Million USD | 3.16% |
| 2023 Q3 | 75.69 Million USD | 2.49% |
| 2023 Q2 | 73.85 Million USD | 5.53% |
| 2022 Q1 | 78.24 Million USD | 29.18% |
| 2022 Q3 | 73.92 Million USD | -11.09% |
| 2022 FY | 75.25 Million USD | 24.24% |
| 2022 Q2 | 83.14 Million USD | 6.26% |
| 2022 Q4 | 75.25 Million USD | 1.8% |
| 2021 Q2 | 62.03 Million USD | 1.37% |
| 2021 Q4 | 60.57 Million USD | 9.49% |
| 2021 Q3 | 55.32 Million USD | -10.81% |
| 2021 FY | 60.57 Million USD | -6.69% |
| 2021 Q1 | 61.19 Million USD | -5.73% |
| 2020 Q2 | 51.9 Million USD | 1.26% |
| 2020 Q3 | 55.06 Million USD | 6.08% |
| 2020 Q4 | 64.92 Million USD | 17.9% |
| 2020 Q1 | 51.25 Million USD | 24.13% |
| 2020 FY | 64.92 Million USD | 57.22% |
| 2019 Q3 | 39.31 Million USD | 13.41% |
| 2019 Q4 | 41.29 Million USD | 5.04% |
| 2019 Q2 | 34.66 Million USD | 11.96% |
| 2019 Q1 | 30.96 Million USD | 18.75% |
| 2019 FY | 41.29 Million USD | 58.38% |
| 2018 Q3 | 23.5 Million USD | -4.44% |
| 2018 FY | 26.07 Million USD | 0.61% |
| 2018 Q2 | 24.59 Million USD | 1.01% |
| 2018 Q1 | 24.35 Million USD | -6.02% |
| 2018 Q4 | 26.07 Million USD | 10.92% |
| 2017 FY | 25.91 Million USD | 9.61% |
| 2017 Q2 | 22.53 Million USD | 3.05% |
| 2017 Q3 | 23.89 Million USD | 6.01% |
| 2017 Q4 | 25.91 Million USD | 8.46% |
| 2017 Q1 | 21.87 Million USD | -7.49% |
| 2016 Q4 | 23.64 Million USD | 0.0% |
| 2016 FY | 23.64 Million USD | 4.86% |
| 2015 FY | 22.54 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -52.347% |
| BrainsWay Ltd. | 15.31 Million USD | -409.886% |
| Cerus Corporation | 144.3 Million USD | 45.889% |
| Envoy Medical, Inc. | 9.4 Million USD | -730.504% |
| electroCore, Inc. | 8.94 Million USD | -772.935% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -1361.7% |
| IceCure Medical Ltd | 4.24 Million USD | -1738.568% |
| Inogen, Inc. | 121.38 Million USD | 35.671% |
| OrthoPediatrics Corp. | 72.56 Million USD | -7.612% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -163.967% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -2353.972% |
| MaxCyte, Inc. | 36.1 Million USD | -116.257% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -4125.53% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -18260.566% |
| Orthofix Medical Inc. | 326.58 Million USD | 76.091% |
| PAVmed Inc | 57.13 Million USD | -36.661% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -206.657% |
| RxSight, Inc. | 22.18 Million USD | -251.92% |
| Sight Sciences, Inc. | 46.43 Million USD | -68.154% |
| SI-BONE, Inc. | 61.05 Million USD | -27.902% |
| TELA Bio, Inc. | 59.16 Million USD | -31.972% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 31.487% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -656.701% |
| Acutus Medical, Inc. | 54.83 Million USD | -42.388% |
| Talis Biomedical Corporation | 29.22 Million USD | -167.191% |
| Spectral AI, Inc. | 12.4 Million USD | -529.659% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -237.529% |
| CVRx, Inc. | 39.28 Million USD | -98.778% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -552.981% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -3114.259% |
| Bioventus Inc. | 589.79 Million USD | 86.761% |
| Venus Concept Inc. | 107.1 Million USD | 27.094% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -51.141% |
| LivaNova PLC | 1.15 Billion USD | 93.221% |
| 908 Devices Inc. | 37.49 Million USD | -108.28% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 88.9% |
| Nemaura Medical Inc. | 26.37 Million USD | -196.026% |
| NeuroPace, Inc. | 86.99 Million USD | 10.245% |
| LENSAR, Inc. | 22.4 Million USD | -248.449% |
| Apyx Medical Corporation | 52.31 Million USD | -49.249% |
| Cutera, Inc. | 518.12 Million USD | 84.929% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -166.244% |
| BioSig Technologies, Inc. | 4.68 Million USD | -1566.681% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -33.781% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -263.384% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 96.441% |
| Axonics, Inc. | 82.35 Million USD | 5.191% |
| Outset Medical, Inc. | 190.91 Million USD | 59.1% |
| IRIDEX Corporation | 24.91 Million USD | -213.414% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 37.011% |
| IRadimed Corporation | 20.73 Million USD | -276.564% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -4564.516% |
| INVO Bioscience, Inc. | 19.99 Million USD | -290.518% |
| Telesis Bio, Inc. | 40.87 Million USD | -91.041% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -91.428% |
| Varex Imaging Corporation | 668.6 Million USD | 88.321% |
| Quipt Home Medical Corp. | 136.29 Million USD | 42.709% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2086.002% |
| Pulmonx Corporation | 60.63 Million USD | -28.775% |
| Dynatronics Corporation | 11.78 Million USD | -562.846% |
| Modular Medical, Inc. | 2.27 Million USD | -3336.796% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1821.358% |
| Semler Scientific, Inc. | 6.27 Million USD | -1145.359% |
| InMode Ltd. | 75.91 Million USD | -2.858% |
| Bruker Corporation | 2.83 Billion USD | 97.247% |
| Cytosorbents Corporation | 29.98 Million USD | -160.406% |
| DexCom, Inc. | 4.19 Billion USD | 98.139% |
| Align Technology, Inc. | 2.45 Billion USD | 96.817% |
| Viveve Medical, Inc. | 10.84 Million USD | -619.867% |
| ZimVie Inc. | 795.85 Million USD | 90.189% |
| Movano Inc. | 5.97 Million USD | -1207.502% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 25.353% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -18260.566% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -552.981% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 87.781% |
| Profound Medical Corp. | 12.66 Million USD | -516.492% |
| Insulet Corporation | 1.85 Billion USD | 95.792% |
| enVVeno Medical Corporation | 2.43 Million USD | -3106.735% |
| Surmodics, Inc. | 65.82 Million USD | -18.627% |
| iCAD, Inc. | 8 Million USD | -875.928% |
| Nuwellis, Inc. | 6.78 Million USD | -1051.681% |
| Biotricity, Inc. | 35.91 Million USD | -117.386% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 64.992% |
| Aethlon Medical, Inc. | 2.47 Million USD | -3048.993% |
| InspireMD, Inc. | 8.14 Million USD | -859.027% |
| PAVmed Inc. | 57.13 Million USD | -36.661% |
| BIOLASE, Inc. | 35.34 Million USD | -120.901% |
| Beyond Air, Inc. | 29.77 Million USD | -162.247% |
| FONAR Corporation | 57.45 Million USD | -35.899% |
| AxoGen, Inc. | 101.16 Million USD | 22.813% |
| Vivani Medical, Inc. | 25.03 Million USD | -211.887% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 11.062% |
| Inari Medical, Inc. | 209.32 Million USD | 62.697% |
| UFP Technologies, Inc. | 118.04 Million USD | 33.852% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -515.295% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -3472.311% |
| Tenon Medical, Inc. | 5.56 Million USD | -1302.623% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -4289.207% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -342.801% |
| AdaptHealth Corp. | 3.15 Billion USD | 97.524% |
| Sintx Technologies, Inc. | 6.59 Million USD | -1084.347% |
| NanoVibronix, Inc. | 2.68 Million USD | -2807.074% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -2086.002% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -1498.444% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 92.526% |
| TransMedics Group, Inc. | 568.84 Million USD | 86.273% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -368.073% |
| NeuroMetrix, Inc. | 1.33 Million USD | -5757.22% |
| Hyperfine, Inc. | 9.8 Million USD | -696.776% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 68.797% |
| Biomerica, Inc. | 2.66 Million USD | -2832.182% |
| Bone Biologics Corporation | 831.4 Thousand USD | -9291.847% |
| AVITA Medical, Inc. | 19.86 Million USD | -293.065% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -3856.258% |
| Silk Road Medical, Inc | 114.15 Million USD | 31.6% |